Ignite Creation Date:
2025-12-24 @ 4:07 PM
Ignite Modification Date:
2025-12-24 @ 4:07 PM
Study NCT ID:
NCT04005066
Status:
COMPLETED
Last Update Posted:
2022-12-19
First Post:
2019-04-18
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Phase IV Study of Elunate® (Fruquintinib) in Chinese Patients
Sponsor:
Hutchmed
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Patient Safety | View |
Keywords: